Get more from your suture with STRATAFIX™ Knotless Tissue Control Devices 

More efficiency and consistency compared to traditional suturing techniques with no need to tie knots1,2 

More efficiency and consistency compared to traditional suturing techniques with no need to tie knots1,2 

More strength* and security than traditional sutures2-6

More strength17 and security than traditional sutures2-6  

28% reduction in surgical site infection risk demonstrated in a meta-analysis with the use of triclosan-coated sutures7†‡§

28% reduction in surgical site infection risk demonstrated in a meta-analysis with the use of triclosan-coated sutures7†‡§

two surgeons operating

More efficiency and consistency18 

With no need to tie knots, STRATAFIX™ can close substantially faster than interrupted suturing. In THAs, for example, a retrospective study showed time savings of 22 minutes!1,2,8,19

Bidirectional devices allow 2 clinicians to close. And with multiple points of fixation, STRATAFIX™ distributes tension evenly for consistent control.1,2,4 

graph showing more strength and security with stratafix sutures

More strength17 and security


STRATAFIX™ anchor technology locks into position with each pass 
and prevents loosening of the device.

STRATAFIX™ Symmetric PDS™ Plus Knotless Tissue Control Device provides 39% greater holding strength than coated VICRYL® (polyglactin 910) Suture, and is the only barbed suture appropriate for closing high-tension areas such as fascia.3,9-13

Help reduce risk factors associated with SSIs

Help reduce risk factors associated with SSIs

STRATAFIX™ are the only commercially available barbed sutures with Plus Antibacterial Technology, proven in vitro to kill bacteria on the suture associated with SSI.14,15,20


For complete indications, contraindications, warnings, precautions, and adverse reactions, please reference full package insert.

† In a meta-analysis that included 21 RCTs, 6462 patients, 95% CI: (14, 40%), P<0.001.

‡ All triclosan-coated sutures in these RCTs were Ethicon Plus Antibacterial Sutures (MONOCRYL® Plus Antibacterial (poliglecaprone 25) Suture, Coated VICRYL® Plus Antibacterial (polyglactin 910) Suture, and PDS® Plus Antibacterial (polydioxanone) Suture).

§ Meta-analysis only included traditional (non-barbed) sutures.

1. Moran ME, Marsh C, Perrotti M. Bidirectional-barbed sutured knotless running anastomosis v classic Van Velthoven suturing in a model system. J Endourol. 2007;21(10):1175-1178. 

2. Vakil JJ, O'Reilly MP, Sutter EG, Mears SC, Belko SM, Khanuja HS. Knee arthrotomy repair with a continuous barbed suture: a biomechanical study. J Arthroplasty. 2011;26(5):710-713. 

3. Nonnenman H. 100326296: Time zero tissue holding - Competitive claims comparisons for STRATAFIX Knotless Tissue Control Devices vs various products. 2015. Ethicon, Inc. 

4. Levine BR, Ting N, Della Valle CJ. Use of a barbed suture in the closure of hip and knee arthroplasty wounds. Orthopedics. 2011;34(9):e473-e475. doi: 10.3928/01477447-20110714-35. 

5. Einarsson JI, Chavan NR, Suzuki Y, Jonsdottir G, Vellinga TT, Greenberg JA. Use of bidirectional barbed suture in laparoscopic myomectomy: evaluation of perioperative outcomes, safety, and efficacy. J Minim Invasive Gynecol. 2011;18(1):92-95. 

6. Eickmann T, Quane E. Total knee arthroplasty closure with barbed sutures. J Knee Surg. 2010;23(3):163-167. 

7. Johnston S, Sutton N. Retrospective, observational study using the Premier® Perspective Hospital Database. Stratafix & Prineo Study. 2017. Ethicon, Inc. 

8. de Jonge SW, Atema JJ, Solomkin JS, Boermeester MA. Meta-analysis and trial sequential analysis of triclosan-coated sutures for the prevention of surgical-site infection. Br J Surg. 2017;104(2):e118-e133. 

9. Ethicon study PSE 09-0204, project number 11822. Exploratory histological and biomechanical evaluation of DOLFIN following closure of the ventral abdominal wall in a porcine model at 7±1 days. July 7, 2010. Ethicon, Inc. 

10. Ethicon study AST-2011-0210. Study to evaluate the tissue holding performance at time zero of DOLFIN PDS PLUS barbed suture sizes 1 and 2-0 vs dyed PDS II Plus suture sizes 1 and 2-0 in a continuous stitch pattern—Project DOLFIN 11822. July 15, 2011. Ethicon, Inc. 

11. Ethicon study AST-2011-0341. Performance testing of DOLFIN PDS PLUS size 3-0 suture–tissue holding 10 cm incision. August 22, 2011. Ethicon, Inc. 

12. Ethicon study PSE 10-0012, project number 11822. Model development: histological and biomechanical evaluation of 3-0 DOLFIN barbed suture prototypes, 3-0 Quill suture, and 3-0 V-loc suture at 7±1 days following closure of the ventral abdominal wall in a rabbit model. August 8, 2011. Ethicon, Inc. 

13. Performance testing of STRATAFIX Symmetric PDS Plus Size 0 & 1 Devices – initiation strength in porcine tissue. AST-2013-0603. Ethicon, Inc. 

14. Ming X, Rothenburger S, Yang D. In vitro antibacterial efficacy of Monocryl Plus Antibacterial Suture (poliglecaprone 25 with triclosan). Surg Infect (Larchmt). 2007;8(2):201-207. 

15. Ming X, Rothenburger S, Nichols MM. In vivo and in vitro antibacterial efficacy of PDS Plus (polidioxanone with triclosan) suture. Surg Infect (Larchmt). 2008;9(4):451-457. 

16. Ethicon study AST-2012-0331. Tissue gapping under tension of porcine cadaveric skin incisions closed with Stratafix Spiral in comparison to Monocryl in both interrupted and continuous stitching patterns. August 24, 2012. Ethicon, Inc.

17. Refers to STRATAFIX Symmetric PDS Plus Device only.

18. Compared to traditional sutures.

19. Based on retrospective analysis of 5,958 total hip arthroplasties from the Premier Perspective® Hospital Database, p<0.05.

20. In an animal model.